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The fungal pathogen, Cryptococcus neoformans, has been shown to undergo
replicative aging. Old cells are characterized by advanced generational age and
phenotypic changes that appear to mediate enhanced resistance to host and antifungal-
based killing. As a consequence of this age-associated resilience, old cells accumulate
during chronic infection. Based on these findings, we hypothesized that shifting the
generational age of a pathogenic yeast population would alter its vulnerability to the
host and affect its virulence. SIR2 is a well-conserved histone deacetylase, and a pivotal
target for the development of anti-aging drugs. We tested its effect on C. neoformans’
replicative lifespan (RLS). First, a mutant C. neoformans strain (sir21) was generated,
and confirmed a predicted shortened RLS in sir21 cells consistent with its known role in
aging. Next, RLS analysis showed that treatment of C. neoformans with Sir2p-agonists
resulted in a significantly prolonged RLS, whereas treatment with a Sir2p-antagonist
shortened RLS. RLS modulating effects were dependent on SIR2 and not observed
in sir21 cells. Because SIR2 loss resulted in a slightly impaired fitness, effects of
genetic RLS modulation on virulence could not be compared with wild type cells.
Instead we chose to chemically modulate RLS, and investigated the effect of Sir2p
modulating drugs on C. neoformans cells in a Galleria mellonella infection model.
Consistent with our hypothesis that shifts in the generational age of the infecting yeast
population alters its vulnerability to host cells, we observed decreased virulence of
C. neoformans in the Galleria host when RLS was prolonged by treatment with Sir2p
agonists. In contrast, treatment with a Sir2p antagonist, which shortens RLS enhanced
virulence in Galleria. In addition, combination of Sir2p agonists with antifungal therapy
enhanced the antifungal’s effect. Importantly, no difference in virulence was observed
with drug treatment when sir21 cells were used for infection, which confirmed target
specificity and ruled out non-specific effects of the drugs on the Galleria host. Thus, this
study suggests that RLS modulating drugs, such as Sir2p agonists, shift lifespan and
vulnerability of the fungal population, and should be further investigated as a potential
class of novel antifungal drug targets that can enhance antifungal efficacy.
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INTRODUCTION
Cryptococcus neoformans is a formidable fungal pathogen that
causes disease in immunocompromised individuals; especially
AIDS patients and organ transplant recipients (Perfect and
Casadevall, 2002). This haploid fungus grows by asexual
reproduction during the course of infection (Alanio et al.,
2011). During asexual reproduction, it undergoes asymmetric
mitotic divisions, and the sum of these divisions determines
its replicative lifespan (RLS) (Steinkraus et al., 2008). In the
course of these divisions, the aging mother cells increasingly
manifests phenotypic changes, including increased cell body
size analogous to changes described in Saccharomyces cerevisiae,
Candida albicans, and Schizosaccharomyces pombe (Fu et al.,
2008; Roux et al., 2010; Yang et al., 2011). Also analogous to
these yeasts, old C. neoformans cells cease to divide at the
completion of their RLS (Bouklas et al., 2013). RLS is different
from chronological lifespan (CLS) as it involves active growth
of the yeast population, whereas CLS is defined as the number
of days non-replicating cells remain viable in a medium with
no nutrition (Fabrizio and Longo, 2007; Cordero et al., 2011).
It is noteworthy that both RLS and CLS affect longevity in
S. cerevisiae, but their relationship does not always correlate (Qin
and Lu, 2006; Fabrizio and Longo, 2007; Barea and Bonatto, 2009;
Murakami and Kaeberlein, 2009).
Recent investigations from our laboratory demonstrated
that the RLSs of individual C. neoformans strains vary and
constitute a stable and reproducible, albeit strain-specific
trait (Jain et al., 2009a; Bouklas et al., 2013, 2015). It
was also shown that C. neoformans undergoes replicative
aging during chronic infection in the human host (Alanio
et al., 2011). Most importantly, our data from human as
well as rat infection indicated that older C. neoformans cells
accumulate in chronic infection because they were selected.
Specifically, old cells were found to be more resistant to
hydrogen peroxide stress, macrophage-mediated killing, and
amphotericin B-mediated killing (Bouklas et al., 2013). This
finding is important because patients with cryptococcosis
primarily die from chronic meningoencephalitis (Perfect and
Casadevall, 2002), and treatment is commonly initiated after
weeks or even months of symptoms. The pathogen’s ability
to evade the host immune response combined with its
ability to replicate and persist in vivo poses a challenge to
effective clearance. Consequently, despite the introduction of
Combination Antiretroviral Therapy and antifungal therapy,
treatment failure, persistent disease, and death remain common
(Perfect and Casadevall, 2002; Park et al., 2009).
Based on our published data on selection and acquired
resilience of older C. neoformans cells (Bouklas et al., 2013),
we hypothesized that emergence, selection, and ultimately
persistence of older C. neoformans cells may constitute an
unanticipated virulence trait that could potentially be modulated
with drug treatment. Consequently, the intriguing question that
has transpired is: could manipulation of RLS in C. neoformans
have an effect on resilience of the yeast population in the host
environment, and therefore indirectly also on virulence? We
investigated this question by using drugs known to manipulate
RLS. Sirtuins are a large family of NAD+-dependent histone
deacetylases that are well-conserved across many species (Greiss
and Gartner, 2009), including C. neoformans. SIR2 has been
implicated in aging in many model organisms (Landry et al.,
2000), including S. cerevisiae (Kaeberlein et al., 1999).
We demonstrate that chemical agonists and antagonists to
Sir2p can result in its activation or inhibition, respectively, and
consequently affect the lifespan and resilience of the pathogen
population in the host.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were carried out with the approval of
the Albert Einstein College of Medicine Institute for Animal
Studies. The protocol number 20091015 was approved by the
Institutional Animal Care and Use Committee at Einstein. The
study was in strict accordance with federal, state, local and
institutional guidelines that include “The Guide for the Care
and Use of Laboratory Animals,” “The Animal Welfare Act,”
and “Public Health Service Policy on Human Care and Use of
Laboratory Animals.” All surgery was performed under ketamine
and xylazine anesthesia, and every effort was made to minimize
suffering.
Strains and Media
Cryptococcus neoformans serotype A VNI strain, H99, was used in
this study (J. Perfect, Duke University). Strains stored at −80◦C
were streaked to single colonies and maintained on Yeast Extract
Peptone agar with 0.05%, or 2% dextrose, or 2% dextrose and
drug [2.5 mM (Sigma Aldrich) INAM plates and respective NA
controls as detailed in a previous publication (McClure et al.,
2012), 1 nM resveratrol (Fisher), 1 nM SirAct (BioVision, Inc.),
1 pM SRT1460 (Fisher), 1–10 pM SRT1720 (Fisher), 1 nM Sirtinol
(Sigma Aldrich)] before RLS analysis. Standard yeast culture
media were employed and described where appropriate. Plasmids
pJAF1, pJAF13, and pUC19 were grown in Escherichia coli on
Luria Bertani (LB) agar plates with ampicillin and have been
described elsewhere (Jain et al., 2009b).
Disruption and Complementation of SIR2
The complete ORF sequence of SIR2 (CNAG_04886.2) obtained
from the Broad Institute was replaced with a neomycin cassette
in H99 cells by homologous recombination using biolistic
transformation in a PDS-1000/He hepta system (Biorad). For
transformation, 5 µg of a purified linear DNA construct was
used containing neomycin under H99 ACT1 promoter control
and a TRP1 terminator in addition to 1,000 bp of up- and
downstream regions of the target ORF. These regions were
amplified from the H99 genomic template using the respective
primers (Supplementary Table 2). The neomycin resistance gene
was amplified from plasmid pJAF1 using primers Neo-F and
Neo-R, and the ampicillin (Amp) resistance gene was amplified
from the pUC19 plasmid using primers pUC19-F and pUC19-R.
All primers contained a Van91I restriction site to permit one-
step directional cloning. Amplified products were restricted with
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Van91I and ligated using Quick ligase enzyme (New England
Biolabs, USA), transformed into XL10 Gold cells (Agilent), and
clones were selected on Amp-LB agar plates and confirmed by
single digestion with Van91I. Clones with the correct construct
were amplified using the primers H99SIR2-Lfor and H99SIR2-
Rrev. Transformants were screened on YPD plates containing
100 µg/ml G418 (neomycin) and further confirmed by PCR.
The wt SIR2 gene was amplified with its native promoter
from the H99 genome template with primers H99SIR2R-For
and H99SIR2R-Rev containing EcoRV and XhoI restriction sites
(Supplementary Table 2). The gene was cloned into plasmid
pJAF13, then linearized using ApaI and randomly inserted into
sir21 cells by biolistic transformation. sir21+SIR2 positive
clones were selected on YPD plates containing 100 µg/ml
nourseothricin (NAT) (Werner Bioagents, Germany). Gene
complementation was confirmed by PCR.
Lifespan Measurement
Replicative lifespan was measured by microdissection as
published in S. cerevisiae (Park et al., 2002) with some
modifications. Briefly, 20–60 C. neoformans cells of each strain
were arrayed on an agar plate maintained at 37◦C. The first
bud of each cell was identified as the virgin mother cell, which
then grew in size with every budding event and could be easily
distinguished. New buds from the mother cell were separated at
the end of each division (1–2 h) using a 50 µm fiber optic needle
(Cora Styles) on a tetrad dissection Axioscope A1 microscope
(Zeiss) at 100x magnification. The plate was returned to the
incubator after each separation, or to 4◦C overnight to prevent
excessive budding. The study was terminated when cells had
failed to divide for 24 h, and then plates were kept incubated for
an additional week to ensure that the failure to divide was from
death, not cell cycle arrest. The RLS of each cell was the sum of
the total buds until cessation of divisions.
Chronological lifespan was determined by adaptation of a
S. cerevisiae protocol (Burtner et al., 2009). Briefly, 2 × 106
cells/ml of the respective strain were grown in YPD medium for
3 days at 37◦C and 150 rpm until they reached stationary phase.
They were then transferred to sterile dH2O, and the number of
viable cells was measured by plating appropriate dilutions every
2 days on YPD agar plates. Colony forming units on the plates
were quantitated at 72 h, and the study was terminated when
99.9% of the cells were dead.
Phenotypic Characterization
For cell and capsule size measurements, C. neoformans
cells were suspended in India ink. All slides were imaged
at 1000X magnification on an Olympus AX70 microscope,
pictures were taken with a Qimaging Retiga 1300 digital
camera using the Qcapture Suite V2.46 software (Qimaging,
Surrey, BC, Canada), and size was measured in Adobe
Photoshop CS5 for Macintosh. At least 100 cells were imaged
per group. Yeast cells were also stained with mAb 18B7
to the capsular polysaccharide glucuronoxylomannan and
visualized with fluorescein isothiocyanate-labeled goat anti-
mouse immunoglobulin G (IgG) (Casadevall et al., 1998).
Switching frequencies, doubling times, capsule induction,
melanization, mating, macrophage-mediated phagocytosis and
killing assays, and MICs of amphotericin B were determined as
previously described (Jain et al., 2009b).
Isolation of Old Cells
Wt or mutant C. neoformans cells were grown in YPD medium
and isolated at 0–2 or 10-generation-old as described previously
(Bouklas et al., 2013). Briefly, newly budded C. neoformans
cells were isolated by elutriation (Beckman JE-5.0 rotor in
a Beckman J-6B centrifuge; Beckman Instruments, Inc.) and
labeled with Sulfo-NHS-LC-Biotin (Thermo Scientific). The
newly budded and labeled cells were grown for several
generations (10 generations), and collected by first binding
them to streptavidin-conjugated magnetic microbeads (Miltenyi
Biotec), then isolating them on a magnetic column (Miltenyi
Biotec). Unbound young yeast cells (0-2 generations old) that
washed off the column and had been exposed to similar
manipulations were used as controls. Purity of old cells was
confirmed by fluorescein isothiocyanate (FITC)-staining of the
streptavidin-labeled cells.
Infection Studies
For infection of Galleria mellonella, a 10 µl suspension of 2× 103
or 2× 104 C. neoformans cells was used to infect larvae (n= 20–
40) (Vanderhorst Wholesale, Inc., St. Marys, OH, USA) in the
last proleg as described previously (Cotter et al., 2000). 10 µl of
drug [2.5 mM isonicotinamide (Sigma Aldrich), 1 nM resveratrol
(Fisher), 1 nM SirAct (BioVision, Inc.), 1 pM SRT1460 (Fisher),
1–10 pM SRT1720 (Fisher), 1 nM Sirtinol (Sigma Aldrich)], or
drug and 0.06 µg/ml AMB was given through a different proleg
every 2 days.
For infection of mice, 5 × 104 C. neoformans cells were used
to infect 6–8 week old female BALB/c mice (n = 10) (National
Cancer Institute, Bethesda, MD, USA) either i.v. or i.t. (Huffnagle
et al., 1991; Mukherjee et al., 1994). The fungal burden was
determined either 4 h or on day 10 by sacrificing mice, and plating
dilutions of homogenized organ suspensions onto YPD plates.
RNA Sequencing and Analysis
Three biological replicates of wt or sir21 cells were grown
in YPD or YEP and 0.05% glucose broth overnight at 37◦C,
and approximately 108 cells were collected and suspended
in 0.5 mm zirconia beads and RLT buffer (Qiagen), then
disrupted mechanically using a mini bead beater (Biospec) for
2 min for a total of four cycles with 1 min intervals on ice.
Following lysis, total RNA was isolated using RNeasy mini kit
(Qiagen) according to the manufacturer’s instructions. RNA
hybridization, data acquisition and analysis were performed by
the Genome Technology Access Centre, Washington University
in St. Louis (GTAC-WUSTL). Briefly, total RNA was first
reverse-transcribed with polyA selection and then sequenced
on an Illumina HiSeq 2000. The raw sequence reads were
then converted to basecalls, demultiplexed, and aligned to a
reference sequence with Tophat v2.0.9 and Bowtie2 v2.1.0. Gene
abundances were derived by HTSeq. Differential expression was
estimated by pair-wise negative binomial tests with EdgeR and
DEXSeq. Gene ontology (GO) enrichment was performed by
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GTAC-WUSTL. Each gene was assigned a GO category per
the Broad Institute’s PFAM annotations using the provided
map1. Any genes with a p < 0.05 by a hypergeometric test
and an FDR q < 0.25 were used to determine significance.
A heatmap of transcriptome data was generated using R
software.
Real-Time PCR
Real-time PCR was performed on RNA isolated from wt or
mutant grown in variable media (2% YPD, or 2% YPD with
2.5 mM isonicotinamide, 1 nM resveratrol, 1 nM SirAct, 1 pM
SRT1460, 1–10 pM SRT1720, 1 nM Sirtinol). The RNA was
cleaned for DNA contamination using the MessageClean kit
(GenHunter, Corp.), and cDNA was synthesized using the First-
strand Superscript II RT kit (Life Technologies) according to
the manufacturer’s instructions. Relative expression of genes
was measured by real-time PCR using SYBR green (Applied
Biosystems) in an ABI 96 system using primers listed in
Supplementary Table 2. Expression levels were performed
in quadruplicates and normalized against the wt grown
in YPD without drug, and relative transcript levels were
determined using the delta-delta CT method. cDNA integrity was
verified by measuring expression levels with β-actin, and DNA
contamination was ruled out by using cDNA made with dH2O.
Statistics
Standard statistical analysis and non-parametric tests, such as
Student’s t-test, Log-rank, and Wilcoxon rank sum tests were
performed using Prism version 6 (Graphpad), or Microsoft Excel
2011 for Macintosh. Differences were considered significant if
p< 0.05.
Data Deposit




Loss of SIR2 Shortens the Replicative
Lifespan of C. neoformans
Sirtuins impact RLS in many diverse organisms, which explains
why they are chosen as a target for the development of RLS
modulating drugs. Protein sequences encoded by SIR2 are
conserved among fungi (Supplementary Table 1). To test the
effect of Sir2p modulating drugs on pathogenesis, a sir21 strain
had to first be generated. SIR2 was deleted by homologous
recombination (Supplementary Figure 1) in a C. neoformans
serotype A VNI strain, H99, by standard techniques (sir21),
and a complemented strain was also generated (sir21+SIR2). As
expected for a lifespan-modulating gene, loss of SIR2 resulted
in measurably impaired fitness. Specifically, a mildly attenuated
in vitro growth in standard rich media (YPD) was observed
(Table 1; Supplementary Figure 2A). However, fitness of sir21
was less affected in calorie restricted (CR) low glucose growth
conditions. Of note is that low glucose growth conditions are
encountered in the host, especially in the brain environment, and
therefore the mutant is still virulent in vivo. A smaller capsule
size was noted in the mutant; however, both the wild type (wt)
and the mutant capsules induced successfully (Table 1). Similar
to S. cerevisiae, the sir21 mutant was unable to mate with its
isogenic mating partner (Table 1).
Replicative lifespan analysis by microdissection confirmed
that SIR2 controls lifespan in C. neoformans (Figure 1A).
Specifically, lifespan analysis determined that the median RLS
of sir21 cells was shortened by 33% relative to the RLS of H99
cells (33 to 22 generations, p < 0.0001). The shortened RLS
was reconstituted to 34 generations in the complemented strain.
RLS was also determined under CR with 0.05% glucose, whereby
0.05% corresponds to the glucose concentration encountered
in human cerebrospinal fluid (CSF). Under CR conditions, the
median RLS of H99 cells was extended by 48% from 33 to
49 generations (p < 0.0001) (Figure 1B). This was dependent
on SIR2, and accordingly RLS analysis of sir21 cells under
TABLE 1 | Characterization of sir21 phenotypes in Cryptococcus neoformans strain H99.
Phenotype Phenotype in the mutant compared to the wt Supporting information
Doubling time in YPD Longer 3.0 vs. 1.9 h (p < 0.01)
Doubling time in 0.05% YPD No measured difference 3.9 vs. 3.2 h
Mating Sterile No mating with Kn99MATa
Chronological lifespan Decreased 20 vs. 24 days
Phenotypic switching rate No switching in either mutant or wt n/a
Capsule size Decreased 0.84 + 0.2 vs. 0.96 + 0.2 µm (p < 0.01)
Total cell size No measured difference 6.48 + 0.8 vs. 6.75 + 0.7 µm
Phagocytosis in murine macrophages No measured difference 81.7 vs. 83.5%
Killing in murine macrophages No measured difference 76.7 vs. 80.5%
Colony sectoring No sectoring in either mutant or wt n/a
GXM staining Same pattern Punctate to 18B7 mAb
MIC to amphotericin B No measured difference 0.25 vs. 0.25 µg/ml
H2O2 resistance No measured difference 3.6 vs. 3.5 cm
Results not significant unless stated otherwise.
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FIGURE 1 | Loss of SIR2 shortened the RLS of strain H99, but had no effect on its virulence. (A) The effect of loss of SIR2 on the RLS of a serotype A VNI
strain, H99, was determined by microdissection of sir21 cells (dashed line) and found to significantly shorten its median RLS by 33% compared to the wt (straight
line). p < 0.0001. The shortened RLS was reconstituted in the complement (dotted line). (B) 0.05% glucose calorie restriction (CR) significantly extended the median
RLS of wt cells by 48%. p < 0.0001. CR had no effect on the RLS of sir21 cells. (C) A slightly attenuated virulence was observed in Galleria mellonella infected with
2 × 103 mutant cells compared to wt cells. Also (D) no significant virulence difference was observed in BALB/c mice injected i.v. with 5 × 104 mutant or wt cells.
(E) sir21 cells crossed the blood-brain barrier equally well-compared to the wt strain as suggested by comparable brain CFUs 4 h after i.v. infection. (F)
10-generation-old sir21 cells significantly resisted killing by murine macrophages compared to 0-2 generation old sir21 cells, and 0–10 generation old wt cells. RLS
experiments with the respective medium (n = 40–60 cells) were performed at the same time. p-values were calculated by Wilcoxon Rank Sum Test. ∗∗p < 0.01.
CR demonstrated no effect. CLS, measured by viability without
nutrition, was not affected by CR, or different in sir21 cells
compared to the wt (Table 1; Supplementary Figure 2B). In
summary, similar to S. cerevisiae, SIR2 function has a major
impact on the RLS of C. neoformans, but loss also has an effect
on its fitness, which has to be taken into consideration when
association of lifespan and virulence is examined.
Loss of SIR2 Impairs Fitness and
Decreases Virulence
Given the impaired fitness, which is seen with most mutants
of RLS modulating genes (Kaeberlein and Kennedy, 2005;
Kaeberlein et al., 2005), we compared the virulence of sir21 and
wt cells in different infection models, including G. mellonella
(waxworm) and two murine models of infection. In Galleria,
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survival was found to be slightly decreased at an inoculum dose
of 2 × 103 CFU (Figure 1C), and significantly decreased at
higher inocula (Figure 3). Consistent with the observed growth
attenuation of sir21 cells in rich medium, sir21 cells exhibited
hypovirulence also in the murine pulmonary infection model
(Supplementary Figure 3), where a lower organ fungal burden
(data not shown) was noted in sir21 infected mice. Interestingly,
comparable survival was observed in the intravenous (i.v.)
model, where growth difference would be expected to be
less pronounced because the brain is a low glucose growth
environment (Figure 1D). Comparable brain CFUs obtained 4 h
after i.v. infection from mouse brain also suggested that both
sir21 and wt cells crossed the blood-brain barrier equally well
(Figure 1E).
Interestingly, despite the expected hypovirulence, resistance
to macrophage-mediated killing at baseline was found to be
comparable in the sir21 and wt cells. This suggests that
hypovirulence is predominantly the result of slightly slower
growth. And more importantly, when killing was compared
in cells aged to 10 generations, resistance was significantly
higher in sir21 cells compared to wt cells of the same
generational age (Figure 1F). Specifically, 10-generation-old
sir21 cells manifested a higher resistance to killing by a
murine macrophage cell line, J774.16, indicating that at 10
generations they were phenotypically older, consistent with their
shortened RLS. Whereas, wt cells, which have a longer RLS
are still younger phenotypically at 10 generations, which is
reflected in their decreased resilience. The reason that this
enhanced resilience does not lead to hypervirulence is most
likely because young sir21 cells grow slower than wt cells in
the nutrient rich environment of the lung. The sir21 cells can
therefore not expand fast enough to undergo selection for older
generations. In summary, these data highlight limitations of
knockout mutants and demonstrate that association of RLS and
virulence cannot be investigated by a genetic approach because
growth, albeit slightly, is impaired by loss of SIR2. The data,
however, indicate that the mutant is potentially valuable because
it can still cause death of Galleria and mice under certain
experimental conditions. Therefore, it is justified to use the
mutant as a control for off-target effects of Sir2p modulating
drugs.
In vitro Effects of Sir2p Agonists and
Antagonists on RLS
We sought to explore if we could identify drugs that
modulate RLS in an individual C. neoformans strain. First, we
explored RLS modulation in vitro. For these experiments, six
drugs were chosen. These included isonicotinamide (INAM),
a nicotinamide isostere, chosen because it extends RLS in
S. cerevisiae by alleviating nicotinamide, the feedback inhibitor to
Sir2p’s deacetylation function (McClure et al., 2012). Additional
Sir2p activators examined were resveratrol, SirAct, and two
small molecules (SRT1460 and SRT1720) that were developed
originally by Sirtris (now GlaxoSmithKline) to activate the
human homolog, Sirt1p. Lastly, we also included a Sir2p inhibitor
(sirtinol).
These studies found that all Sir2p agonists, except SRT1720,
had a prolongevity effect on C. neoformans (Figure 2).
Specifically, INAM extended the median RLS of H99 cells
restricted for nicotinic acid (NA) by 46% from 28 to 41
generations (p < 0.0001) (Figure 2A). Resveratrol extended the
median RLS of H99 cells by 32% from 31 to 41 generations
(p= 0.006) (Figure 2B). SirAct extended the median RLS of H99
cells by 41% from 27 to 39 generations (p = 0.01) (Figure 2C).
Finally, SRT1460 extended the median RLS of H99 cells by 39%
from 27 to 37.5 generations (p= 0.04) (Figure 2D). SRT1720 was
found to be toxic to cells at nM concentrations, and when titered
down to non-toxic concentrations of 1–10 pM, it was found to
have no significant effect on RLS of H99 cells (Figure 2E). As
would be expected for Sir2p agonists, RLS prolongation required
the presence of SIR2, and therefore no prolongevity effect was
observed with sir21 cells for all the RLS drugs tested (Figure 2).
In addition, we documented the opposite effect on RLS with
sirtinol, a Sir2p inhibitor. Exposure to this drug shortened the
median RLS of H99 cells by 20% from 31 to 25 generations
(p= 0.006) in a Sir2p-dependent manner (Figure 2F).
Effects of RLS Modifying Drugs on
Virulence in Galleria
Next the effect of RLS modifying drugs was tested in vivo.
We chose the Galleria infection model because phagocytic cells
constitute the predominant host response in this model (Aperis
et al., 2007), and drug treatment is easily executed. Older
C. neoformans cells are not truly more virulent (Bouklas et al.,
2013), rather they should be viewed as more resilient to clearance
by host cells, and therefore persistence of older cells is the
consequence of selective preferential killing of younger cells.
We have previously shown that old cells are more resistant to
phagocytosis and killing by macrophages (Bouklas et al., 2013).
We explored if RLS modulating drugs would affect clearance.
Importantly, neither the RLS drugs, nor PBS alone had an effect
on non-infected waxworms (Supplementary Figure 4). When
INAM was given on alternate days to waxworms infected with
H99 at an inocula of 2 × 104 cells, we observed decreased
virulence relative to sham-treated waxworms, measured as a
significantly prolonged survival of the waxworm (Figure 3A).
Similar decreased virulence of H99 was observed in waxworms
with resveratrol treatment (Figure 3A). To control for off
target effects, we tested the drugs also in Galleria infected
with sir21 cells, where you would not expect an effect if
the RLS modulating drug works strictly through Sir2p. As
expected because of slightly impaired fitness, the sir21 infected
waxworms die later compared to wt H99 infected waxworms
(Figure 3B). However, these experiments confirmed specificity
because the effect of RLS modulating drugs on waxworm survival
was dependent on Sir2p, and neither INAM, nor resveratrol
treated waxworms infected with sir21 cells exhibited a survival
difference when compared to untreated controls. Consistent
with our hypothesis that prolongation of RLS lessens virulence,
whereas shortening of RLS enhances virulence, we found that
treatment with the Sir2p inhibitor, sirtinol, had the opposite
effect and enhanced virulence, and therefore decreased waxworm
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FIGURE 2 | Multiple Sir2p agonists and an antagonist altered the RLS of H99. (A) INAM extended the median RLS of H99 cells in NA-depleted conditions by
46%, (B) resveratrol by 32%, (C) SirAct by 41%, and (D) SRT1460 by 39%, respectively (all p < 0.04). In contrast (E) 1–10 pM SRT1720 failed to extend the median
RLS of H99 cells or was toxic to Cryptococcus neoformans. As expected, the SIR2 antagonist (F) sirtinol significantly shortened the median RLS of H99 cells by 20%
(p = 0.006). RLS experiments with the respective drug (n = 40–60 cells) were performed at the same time. p-values were calculated by Wilcoxon Rank Sum Test.
survival was documented (Figure 3A). This drug effect was
again SIR2 dependent (Figure 3B). For waxworms treated
with SirAct and SRT1460, significantly increased waxworm
survival was also observed (Figure 3C), whereas toxicity or
no effect was seen with SRT1760 (data not shown). The
latter was predicted by the in vitro RLS data (Figure 2).
However, for SRT1460 and SirAct, we found that changes
in virulence were not Sir2p-dependent because drug-treated
waxworms infected with sir21 cells also lived significantly
longer compared to sham-infected (Figure 3D; Supplementary
Figure 4).
Effect on RLS Drugs in Combination with
Antifungals
Next we tested the effect of RLS modulating drugs in combination
with antifungal therapy. Previous work demonstrated that
sensitivity of C. neoformans cells to amphotericin B (AMB) is
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FIGURE 3 | Sir2p agonists and antagonist alter virulence of H99 in Galleria. (A) INAM and resveratrol given to waxworms infected with 2 × 104 H99 cells
resulted in their prolonged survival, whereas sirtinol treatment resulted in decreased survival. (B) Lifespan effects were dependent on Sir2p and not observed when
infections were done with sir21 cells. (C) SirAct and SRT1460 given to waxworms infected with 2 × 104 H99 cells resulted in their prolonged survival. (D) Lifespan
effects were dependent on Sir2p and not observed when infections were done with sir21 cells. Virulence experiments with the respective drug (n = 20–40 worms)
represent duplicate experiments and were performed with the respective mutant at the same time. p-values were calculated by Log-Rank test.
dependent on the generational age of the cell and enhanced
antifungal-efficacy is observed in younger cells (Jain et al.,
2009a; Bouklas et al., 2013). Therefore, we tested if concomitant
treatment with Sir2p agonists would enhance antifungal efficacy
in H99-infected waxworms that were treated with sub-
therapeutic levels of AMB. Both INAM (Figure 4A) and
resveratrol (Figure 4C) resulted in significantly increased
waxworm survival relative to treatment with RLS or antifungal
drug alone. Again, no enhanced survival benefit was observed in
the mutant-infected waxworms that received the RLS drug and
AMB treatment in combination (Figures 4B,D). Here only, AMB
treatment prolonged survival. No significant increase in survival
was observed with sirtinol-treated waxworms that received AMB
(Figure 4E); and, this effect was SIR2-dependent (Figure 4F).
Effect of RLS Drugs on SIR2 Expression
Lastly, quantitation of SIR2 expression by RT-PCR in strains
grown with the Sir2p agonists or antagonist confirmed a drug-
dependent SIR2 regulation in H99. It is noteworthy that RLS
modulating drugs do not affect doubling times significantly
(Table 2). Specifically, compared to untreated H99 cells,
significant upregulation of SIR2 expression was documented in
response to INAM, resveratrol, and SirAct treatment in H99, and
significant downregulation of SIR2 expression was documented
in response to sirtinol (Figure 5). SIR2 expression was not
significantly regulated under SRT1460 or SRT1720.
Sir2p is Involved in Several Biological
Processes in C. neoformans Consistent
with the Pleiotropic Effects Observed
from SIR2 Loss
Lastly, the transcriptome of sir21 and wt H99 cells grown
in rich media or under more physiologic CR media was
compared by RNA sequencing (GEO accession #GSE74298).
Grown in rich media (RM: YEP + 2% glucose), 25 genes
were down- and 3 genes were upregulated in sir21 cells (fold
change ≤ 1.5-fold, p < 0.05). As expected, more pronounced
transcriptional regulation was found in CR media (CR: YEP +
0.05% glucose), where 232 genes were down- and 80 genes up-
regulated (FC ≤ 1.5-fold, p < 0.05). A heatmap was generated
(Figure 6), and GO analysis was performed to assign the genes
affected by SIR2 loss to GO categories. In rich media, enriched
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FIGURE 4 | Adjunctive treatment of Sir2p agonists with amphotericin B enhanced antifungal efficacy. Treatment with Sir2p agonists, (A) INAM or (C)
resveratrol, and 0.06 µg/ml AMB enhanced antifungal efficacy in H99-infected worms. (B,D) Lifespan effects were dependent on Sir2p and not observed when
infections were done with sir21 cells. (E) The Sir2p antagonist (sirtinol) had a reverse, albeit minimal, effect that was notably (F) Sir2p-dependent. Virulence
experiments with the respective drug (n = 20–40 worms) represent duplicate experiments and were performed with the respective mutant at the same time.
p-values were calculated by Log-Rank test.
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TABLE 2 | Doubling times (h) of H99 and sir21 under RLS-modifying drugs.
Growth conditions H99 sir21
YPD only 3.2 3.8
2.5 mM INAM in YPD 3.1 3.6
1 nM resveratrol in YPD 2.9 3.7
1 nM SirAct 3.4 3.7
10 pM SRT1460 2.8 3.7
10 pM SRT1720 3.3 3.6
1 nM Sirtinol 3.1 3.3
Results not significant unless stated otherwise.
GO categories included the biological processes of vesicle- and
ER to Golgi vesicle-mediated transport, intracellular protein
transport, and the cellular components of Golgi apparatus, cell
division site, and cell tip. In CR growth conditions, GO analysis
assigned genes affected by SIR2 loss to the following distinct
biological processes: transmembrane transport, transcription and
translation, molecular functions of transporter activity, and the
cellular components of cell membrane, ribosome, nucleolus,
and mitochondria. Although minimal overlap with respect to
specific genes (2%) was noted for the transcriptomes under
RM and CR, some common GO pathways overlapped (21%),
including transmembrane and transport activity, translation,
and the cellular components of mitochondria and ribosomes.
Comparison with S. cerevisiae transcriptome data (Cherry et al.,
2012) identified common GO categories, such as negative
regulation of DNA recombination, regulation of DNA-templated
transcription, NAD-dependent histone deacetylase activity, and
the nucleolus (asterisk in Figure 6). Thus, a role of SIR2 in
transport and several intracellular cell components, particularly
under nutrient-limiting conditions is suggested and explains the
pleiotropic phenotype observed in the mutant.
DISCUSSION
Recent investigations on replicative aging in C. neoformans
(Jain et al., 2009a; Bouklas et al., 2013) indicate that older
C. neoformans cells of advanced replicative age are selected in vivo
during chronic infection. Furthermore, data indicated that old
cells are selected because their phenotype is more resilient in the
setting of chronic disease. Accordingly, we demonstrated that 10-
generation-old cells were more resistant to antifungal therapy
and phagocytic killing. In this study, we present evidence that
modulation of RLS in the C. neoformans strain, H99, through
treatment with Sir2p agonists changes the vulnerability/resilience
of the pathogen population, and therefore an impact on virulence,
as well as sensitivity to antifungal therapy is observed.
The question of whether a shortened or extended RLS confers
a benefit to a C. neoformans strain is challenging to investigate
because lifespan is a dynamic trait that has to first emerge,
and in addition lifespan (Bitterman et al., 2003; Jazwinski, 2004;
Steinkraus et al., 2008; Bouklas et al., 2013, 2015), and virulence
(Adler et al., 2011; Haynes et al., 2011; Kronstad et al., 2012;
Zaragoza and Nielsen, 2013; Sabiiti et al., 2014) are regulated
FIGURE 5 | SIR2 expression was differentially regulated by chemical
drugs. H99 cells grown in the presence of Sir2p agonists (INAM, resveratrol,
SirAct) showed a higher expression of SIR2 as measured by RT-PCR,
compared to cells grown in the absence of agonists, or the presence of the
Sir2p antagonist, sirtinol. RT-PCR was performed in quadruplicates and
normalized to β-actin. p-values were calculated by Student’s t-test. ∗p < 0.05,
∗∗p < 0.01.
by multiple factors. A straightforward reductionist approach,
where RLS is modified through loss of a longevity-promoting
gene, is therefore not feasible. In addition, a genetic approach
is hampered by the fact that longevity-regulating genes in
S. cerevisiae also regulate fitness (Kaeberlein and Kennedy, 2005;
Kaeberlein et al., 2005). This is also true for known homologs in
C. neoformans; for instance, the tor11mutant is not viable (Cruz
et al., 2001), the ras11mutant grows slower (Waugh et al., 2002),
and the sch91 mutant has an altered polysaccharide capsule
(Wang et al., 2004), and would not constitute as adequate targets
to answer that question. Therefore, changes in virulence in these
C. neoformans mutants cannot be related to changes in RLS.
SIR2 homologs are among the most intensely investigated
lifespan modulating genes. In S. cerevisiae, loss of SIR2 shortens
RLS, while overexpression results in extension of RLS (Kaeberlein
et al., 1999). SIR2 prolongevity effects have been reported in other
eukaryotes (Tissenbaum and Guarente, 2001; Wood et al., 2004;
Guarente, 2007), and drugs that alter Sir2p function are being
actively pursued (Baur et al., 2012). However, Sir2p is a histone
deacetylase (Guarente and Kenyon, 2000) that regulates over 100
genes in S. cerevisiae (Cherry et al., 2012). Pleiotropic effects in
the sir21 also include loss of fitness (Kaeberlein and Kennedy,
2005; Kaeberlein et al., 2005).
In this study, we first investigated the loss of Sir2p function
in the standard serotype A VNI strain, H99, which is derived
from a patient and used for experiments by the majority of
laboratories that investigate C. neoformans. Consistent with
RLS studies in S. cerevisiae (Lin et al., 2000; Kaeberlein
et al., 2004), sir21 C. neoformans cells exhibited a significantly
shortened median RLS that was regained with reconstitution.
As predicted by S. cerevisiae and other model organisms
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FIGURE 6 | A loss of SIR2 in calorie-restricted media affects multiple
biological pathways consistent with the observed pleiotropic
phenotype. A heatmap of transcriptomes shows upregulation of ribosome
biogenesis genes, transcription and translation, and NAD-regulating genes, as
well as downregulation of mating genes. Common gene ontology (GO)
categories were also found from similar transcriptome mining in
Saccharomyces cerevisiae and are highlighted with an asterisk.
of aging (Wood et al., 2004; Guarente and Picard, 2005;
Fontana et al., 2010; Skinner and Lin, 2010), CR was found
to prolong lifespan in C. neoformans as well. CR is modeled
in yeast by reduction of glucose content from 2 to 0.05%
(Lin et al., 2002; Kennedy et al., 2005). Extension of lifespan
through CR was dependent on SIR2 in H99. Accordingly,
SIR2 was upregulated in H99 cells under CR. It is noteworthy
that so far, the majority of lifespan studies under CR have
been conducted in primarily fermentative Crabtree-positive
yeasts, such as S. cerevisiae and Schizosaccharomyces pombe,
and only a few studies in the primarily respiratory Crabtree-
negative yeasts, Candida albicans and Kluyveromyces lactis, are
emerging (Skinner and Lin, 2010). C. neoformans is an obligate
aerobic yeast, but can tolerate some hypoxic stress (Chun
et al., 2007). CR in Crabtree-negative and in obligate aerobic
yeasts does not activate a fermentation-to-respiration switch.
Thus, C. neoformans provides a unique platform to study the
respiration switch-independent mechanisms of CR.
FIGURE 7 | A schemata highlights the relationship between virulence
and resilience of the pathogen population, and the effect of RLS
modulating drugs on lifespan.
Sirtuins have been implicated in a wide range of cellular
processes beyond aging. Our transcriptome data confirm this.
We found that genes involved in many diverse biological
processes are regulated. As expected, regulation is greatly
enhanced under CR conditions. Important virulence-associated
traits that were altered in H99 sir21 cells include a mating
defect and impaired growth, which is physiologically more
relevant in the host environment. Notably the growth defect was
not significant under CR growth conditions. Other virulence-
associated properties, such as melanization, H2O2 resistance,
phagocytosis, and killing in macrophages were not affected
by loss of SIR2 in young cells. The capsule difference was
judged as minor, and capsule was inducible regardless of SIR2
loss. Impaired growth in the mutant cells underscores the
aforementioned predicament, namely that RLS mutants cannot
be used to determine if the length of RLS affects virulence.
Fortunately, the sir21 was virulent in the G. mellonella infection
model despite mildly attenuated growth, which allows us to use
this mutant as a valuable control. Even in rodents, the sir21
mutant could be used as a control in the CNS model because it
is virulent and can cause death in mice.
Over the past two decades, genetic approaches using diverse
organisms have identified 100s of aging genes and highlighted
evolutionary conservation among longevity pathways between
disparate species (Managbanag et al., 2008). Although the major
driving force of aging research is its application to novel therapies
against chronic disease and direct extension of human lifespan,
our intention was to test SIR2 modifying anti-aging drugs with
respect to their ability to alter the median RLS of eukaryotic
pathogen populations. Given that cells of advanced generational
age exhibit enhanced resistance to phagocytic killing, and to
antifungals (Jain et al., 2009a; Bouklas et al., 2013), it was
reasonable to hypothesize that in a C. neoformans strain with a
prolonged RLS, the resilient old age phenotype would emerge
later, and therefore would contribute to decreased resilience and
virulence of the pathogen population (Figure 7).
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Significantly, increased longevity was achieved in H99 cells
in vitro with four of the five tested Sir2p agonists. As expected,
the opposite effect on RLS was observed with the Sir2p inhibitor,
sirtinol. SRT1460 and SRT1720 are high affinity small molecules
that were designed to bind to the human Sir2p analog, Sirt1p
(Milne et al., 2007), and therefore it was not surprising that
SRT1720 did not prolong RLS in C. neoformans. SRT1460 had
a statistically significant prolongevity effect. Both did not induce
fungal SIR2 in vitro. Resveratrol, a stilbenoid, is an established
anti-aging drug that has a significant prolongevity effect on
the RLS of S. cerevisiae (Howitz et al., 2003), and also on
other model organisms (Baur et al., 2006; Bass et al., 2007).
In C. neoformans, we documented a significant prolongevity
effect on RLS as well. The prolongevity effect of resveratrol in
S. cerevisiae is SIR2-independent (Kaeberlein and Kennedy, 2007;
McClure et al., 2012), but this is strain dependent. Our data,
however, indicate that for the C. neoformans strain, H99, the
prolongevity effect was dependent on SIR2. Future studies with
the sir21 in other C. neoformans strain backgrounds would
have to be done to confirm consistent dependence on SIR2.
INAM is a nicotinamide isostere that extends RLS in S. cerevisiae
by alleviating nicotinamide, an NAD+ precursor and feedback
inhibitor to Sir2p’s deacetylation function (McClure et al., 2012).
This drug is thought to extend RLS only through the action
of Sir2p in S. cerevisiae. In C. neoformans, this was confirmed.
SirAct is a carboxamide, which was developed to treat aging
related diseases in humans (Nayagam et al., 2006). Our results
demonstrate that this drug also has a significant Sir2p dependent
effect on C. neoformans RLS.
Based on our in vitro data, we sought to test the effect
of RLS modulating drugs in an in vivo virulence model in
Galleria. Indeed, these data confirmed that RLS modulating
drugs could have an impact on virulence. We demonstrated that
RLS prolonging drugs increase survival and decrease virulence
in Galleria, whereas RLS shortening drugs decrease waxworm
survival when infected with H99 wt cells. In addition, our
experiments showed that RLS modulating drugs could enhance
the antifungal efficacy of amphotericin B in C. neoformans
infected Galleria. This effect is not seen when sirtinol, which
shortens RLS, or in all the cases where waxworms were infected
with sir21 cells instead of the wt. We propose that prolongation
of RLS alters vulnerability in vivo as it shifts the median RLS to
a younger pathogen population, which has not acquired the old
age phenotype yet.
One concern is that the drugs could have an independent
effect on the host’s virulence. Resveratrol, for instance, inhibits
laccase activity and melanization in C. neoformans cells (Fowler
et al., 2011). However, the fact that sir21 infected Galleria do
not exhibit the same changes in virulence suggests that the
decreased virulence is dependent on fungal-specific Sir2p. It is
also noteworthy that doubling times are not significantly affected
by drug treatment. RNA transcriptome comparison of H99 in CR
conditions demonstrates upregulation of SIR2 under CR. Most
importantly, published transcriptome data from CNS derived
C. neoformans cells (Chen et al., 2014) also demonstrate that
SIR2 is upregulated in yeast derived from the CSF. Hence, future
studies in rodent models constitute a rational approach to further
explore this expanding class of drugs (Zhai et al., 2012). An
additional concern is that the drugs could have an independent
effect on mammalian cells, which share the homologous Sirt1p.
Recent successful designs of human specific Sirt1p agonists
suggest that with proper medicinal chemistry (Nayagam et al.,
2006; Milne et al., 2007), it may be possible to produce fungal-
specific Sir2p analog(s) that have minimal off-target effects. Our
data with Galleria suggest that SRT1460 has off-target and Sir2p-
independent effects on the host that may affect survival. This
effect, however, is not observed for INAM or resveratrol.
Finally, our data further support a more complex
understanding of pathogenesis, whereby the median RLS of
a strain may not matter per se, but age-related resilience should
be viewed as an emerging virulence trait of a pathogen population
that may come as a trade-off for fitness. This naturally acquired
old age phenotype, once selected could become dominant in the
pathogen population, and indeed impact outcome and affect
persistence (Figure 7). Our data strongly suggest that this process
can be harnessed and targeted with drugs, which opens up a new
class of antifungal drug targets. Importantly, this novel concept
of generational phenotypes that promotes their selection within
a pathogen population may be relevant to other eukaryotic
pathogen populations, many of which cause chronic diseases
that are notoriously difficult to treat, and for which new drug
targets are desperately required. Aging related phenotypes are
not present in overnight cultures and only become relevant in the
host environment because a highly selective host response has to
be present in vivo to drive selection, and permit the emergence of
older cells in the host.
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